Oxytocin
Oxytocin News
Explained: What is Oxytocin and why does the govt want to ban its commercial use?
The health ministry in April 2018 notified a ban on private firms from manuacturing and selling oxytocin, stating that it wanted to restrict the responsibility of supplying the drug to a Karnataka-based public sector manufacturer to avoid its misuse in the veterinary field.
PSU authorised to be sole oxytocin supplier was red-flagged for substandard batch
The Indian Express reported in November 2016 that Gujarat’s drug regulator had found that KAPL had manufactured a substandard batch of important stomach medication omeprazole, which failed tests to check the time the drug takes to dissolve into the blood stream.
Advertising
HealthMin pushed for PSU to be sole Oxytocin producer even as selected firm was put up for sale
The Health Ministry, in April 2018, first announced it was banning the import of Oxytocin and preventing private firms from manufacturing it for domestic use.
Oxytocin ban: IMA moves application in SC to oppose Centre’s position
Health ministry in April 2018 notified a ban on private firms from manufacturing and selling oxytocin, used to prevent new mothers from excessively bleeding after giving birth.
Delhi HC sets aside govt order banning private firms from producing, selling oxytocin
Oxytocin is naturally secreted by the pituitary glands of mammals during sex, childbirth, lactation or social bonding, and is sometimes called “love hormone”
No Oxytocin seized in 2016-18: CDSCO informs Delhi High Court
In 2016-17, the central regulator -- Central Drugs Standard Control Organisation (CDSCO) -- did not seize any raw material (or the Active Pharmaceutical Ingredient) used in the manufacturing Oxytocin while in 2017-18, it seized just 614 grams of the API.
Advertising
Oxytocin production by private companies: Delhi HC defers ban to November 1
The three petitioners in this case are Mylan Laboratories, Neon Laboratories and All India Drug Action Network (AIDAN). Pfizer and Mylan are two leading producers of Oxytocin in India.
Reasons for Mylan’s Delhi High Court move: Oxytocin stock, doubts over investment returns
Till April this year, Mylan had around 50 per cent share in sales by volume of the Indian Oxytocin market.
Oxytocin: There must be threshold to define drug’s misuse as rampant, says Delhi High Court
Oxytocin is administered to pregnant women to “prevent and treat” postpartum haemorrhage (PPH). PPH accounts for about 35 per cent of all maternal deaths, says the World Health Organization.
Oxytocin: Delhi High Court asks for data, regulator raids at least 3 factories
The CDSCO official added that the data is being collected to check if the Oxytocin is being diverted by any such private licensed manufacturer “at any stage of production”.
Advertising